These results are in line with the FSHD etiopathogenetic mechanism, which supports a toxic expression of DUX4 as a consequence of LOF mutations in SMCHD1 [2,17]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.